Robin LaChapelle - 19 Sep 2024 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Role
Chief Operating Officer
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact For: Robin LaChapelle
Issuer symbol
AVBP
Transactions as of
19 Sep 2024
Net transactions value
+$90,481
Form type
4
Filing time
23 Sep 2024, 18:14:19 UTC
Previous filing
25 Jan 2024
Next filing
14 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVBP Common Stock Options Exercise $16,848 +2,700 +2.8% $6.24 99,717 19 Sep 2024 Direct
transaction AVBP Common Stock Options Exercise $6,537 +2,867 +2.9% $2.28 102,584 19 Sep 2024 Direct
transaction AVBP Common Stock Options Exercise $16,334 +7,164 +7% $2.28 109,748 19 Sep 2024 Direct
transaction AVBP Common Stock Options Exercise $5,634 +2,471 +2.3% $2.28 112,219 19 Sep 2024 Direct
transaction AVBP Common Stock Options Exercise $45,129 +12,364 +11% $3.65 124,583 19 Sep 2024 Direct
holding AVBP Common Stock 394,477 19 Sep 2024 Held by The MAKS Yao Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Options Exercise $0 -2,471 -50% $0.000000 2,460 19 Sep 2024 Common Stock 2,471 $2.28 Direct F2
transaction AVBP Stock Option (right to buy) Options Exercise $0 -2,867 -11% $0.000000 22,637 19 Sep 2024 Common Stock 2,867 $2.28 Direct F3
transaction AVBP Stock Option (right to buy) Options Exercise $0 -7,164 -32% $0.000000 15,473 19 Sep 2024 Common Stock 7,164 $2.28 Direct F3
transaction AVBP Stock Option (right to buy) Options Exercise $0 -12,364 -40% $0.000000 18,865 19 Sep 2024 Common Stock 12,364 $3.65 Direct F4
transaction AVBP Stock Option (right to buy) Options Exercise $0 -2,700 -4.6% $0.000000 56,471 19 Sep 2024 Common Stock 2,700 $6.24 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the Trustee of The MAKS Yao Trust and may be deemed to have shared voting and investment power over the shares held by The MAKS Yao Trust. The Reporting Person does not have a pecuniary interest in and disclaims beneficial ownership of the shares held by The MAKS Yao Trust.
F2 The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
F3 The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
F4 The shares underlying this option vested as to 25% on February 1, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
F5 The shares underlying this option vested as to 25% on August 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.